Search: 2018 EU Meeting Attendees
Results 81 - 100 of 201

Ruth Herman

Business Development Director, New Business
Ashfield HealthCare Communications

Type of Company:
Communications Agency

Mette Holt

Senior Global Publication Manager
Novo Nordisk

Type of Company:
Pharmaceutical
Professional Degrees: MS
CMPP Certified: (3/2018)

Katharine Howe

Scientific Director
COMPLETE MEDICAL COMMUNICATIONS

Type of Company:
Communications Agency
Professional Degrees: PhD
CMPP Certified: (3/2017)

Jennifer Howell Rainer

Account Manager
Meditech Media

Type of Company:
Communications Agency
CMPP Certified: (3/2016)

Moira Hudson

Senior Medical Writer, Global Medical Communications
ICON Plc

Type of Company:
Contract Research Organization
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (9/2015)

Karen Irving

Scientific Team Leader
CMC Connect

Type of Company:
Communications Agency

Marianne Jenal-Eyholzer

Associate Director Scientific Publications, Global Medical Affairs
Shire International GmbH

Type of Company:
Pharmaceutical
Professional Degrees: CMPP, PhD
CMPP Certified: (3/2013)

Rachel Jones

Patient Engagement Consultant
admedicum Business for Patients GmbH & Co KG

Bio: Rachel Jones started her career as a Community Pharmacist in the UK Healthcare system and she quickly realised that her role was most valuable when she equipped people with the information and tools to understand their own health and the medicines that were needed as part of their care. In her most recent role within AstraZeneca, Rachel has been charged with inputting the patient centric strategy as a Global, companywide initiative. One of her key land mark projects has been to facilitate a consumer charter for the company which was led by patients and their families to add insight and direction to the way in which a large corporate body conducts its business. She is also mid way through her masters in Behavioural Change and is the senior author on a peer reviewed manuscript which was published in the BMJ in 2016 in relation to patient centricity.

Christiane Kerneur

Lead, Publication Standards, Global, Publications
Medical Affairs

Type of Company:
Pharmaceutical
Professional Degrees: PhD

Robert Kiley

Head of Open Research
Wellcome Trust

Bio: Robert Kiley is Head of Open Research at the Wellcome Trust where he is responsible for developing and implementing an open research strategy. The overarching aim is to help ensure that researchers are equipped, empowered and motivated to make research outputs findable, accessible and usable and to use these outputs to accelerate research and improve health. Over the past decade Robert has played a leading role in the implementation of Wellcome's open access policy and overseeing the development of the Europe PubMed Central repository. Robert also acts as the point of contact for eLife, the open-access research journal, launched in 2012 with the support of the Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust, and more recently championed the work to create a new open publishing platform for Wellcome researchers - Wellcome Open Research. Robert is a qualified librarian and an Associate Member of CILIP. Robert also sits as a Director on the ORCID Board.

Karen King

n/a
Complete Medical Communications
CMPP Certified: (9/2012)

Christine Kleemann

Medical Publication Manager, Medical Capabilities Germany
Bristol-Myers Squibb

Type of Company:
Pharmaceutical
Professional Degrees: MPH
Other Degrees*: Dr. rer. hum. biol.

Elizabeth Knowles

Associate Editorial Director, Medicine & Health
Taylor & Francis Group

Type of Company:
Publisher
Professional Degrees: BA/BS

Bio: Liz is Associate Editorial Director for the Medicine & Health journals at Taylor & Francis and has worked on medical journals for the last 10 years. She currently works on the rapid publication journals CMRO and Postgraduate Medicine as well as with the in house Expert Collection commissioning team. In addition, Liz has recently begun working on the Dove Medical Press journals that were recently acquired by Taylor & Francis. Her role is to find the most relevant journal for content being submitted to Taylor & Francis by medical communication and pharmaceutical companies, as well as academics.

Tim Koder

Communications Director
Oxford PharmaGenesis Ltd

Type of Company:
Communications Agency

Bio: Tim has a strong interest in practical improvements that we can make to medical and scientific publishing. Through Neuroscience BSc at UCL then MSc, PhD and a brief postdoc on the neuropharmacology of recognition memory at the University of Bristol, it was more the discussion of science than the bench work that satisfied. Tim moved from the lab to publishing, first as a Production Editor on medical books at Taylor & Francis then as a Development Editor on trade publications and websites at Informa Healthcare. To move closer to the science content, Tim joined Caudex in 2007, and trained as a medical writer and account manager. Wider experiences gained at Communigen and Ogilvy HealthWorld have led to a Communications Director role at Oxford PharmaGenesis. Tim's primary job at Oxford PharmaGenesis is to improve clients' medical affairs capabilities, especially in medical evidence, by simplifying connections between local companies and global functions, with strategy, digital systems and human contact. Publications, medical communications, patient engagement, and other work supporting medical affairs increasingly depend on evidence. To create credible evidence means choosing the right means of engagement, data collection and analysis, then communication. Publications remain central to this process, and the quality threshold of the publication process is playing a stronger role than ever in informing evidence planning. At the point of publication though, there are some well-known problems with speed, transparency and accessibility. To play a role in addressing this, Tim leads the Open Pharma project, facilitating the conversation between pharma publications teams, publishers and other stakeholders, to identify together how innovations in publishing can improve the model for disseminating pharma research.

Jesper Konradsen

Senior Global Publications Manager, Global Publications
Novo Nordisk

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP
CMPP Certified: (3/2017)

Kay Koyander

Global Publications Leader, Global Medical Affairs
AstraZeneca

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS
CMPP Certified: 3/2015

Evelin Kozma

Manager of Scientific Publications and Medical Writing, Clinical R&D
Mundipharma Research Limited

Type of Company:
Pharmaceutical
Professional Degrees: PhD
CMPP Certified: (9/2013)

Christine Krenca

International Business Development Director, Sales and Marketing
Content Ed Net Communications S.L.

Type of Company:
Communications Agency

Claudia Kuenzel

Country Publication Manager
Roche Pharma AG

Type of Company:
Pharmaceutical

Paul Lane

Associate Director Medical Communications
Biomarin Pharmaceutical Inc

Type of Company:
Biotechnology
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (3/2010)

Bio: Paul conducted his Doctoral research into the physiological roles of nitric oxide at Weill Medical College of Cornell University. After serving on the faculty at Weill, Paul worked as a freelance consultant specializing in start-up grants for biotechnology companies, before transitioning full-time to medical publications. He has been a publications professional for over 10 years and has worked on programs spanning all stages of drug development in a variety of therapeutic areas. Until recently, Paul was responsible for Digital and Social Media strategy at Envision Pharma Group, but has now moved on to run publication programs for various rare diseases at Biomarin. The shift from print to web-based publications has been an area of interest since Paul authored a review in one of the first online journals (Science:STKE) in 2001. Much has changed since then, with journals and congresses now offering a plethora of enhancements and the rise of social media as a channel for information dissemination. These additions not only change the way in which medical information is consumed, but also the methods we use to assess the impact of a publication.
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>